UBS Group’s Future Health ESG Corp. Common stock FHLT Stock Holding History

UBS Group’s Portfolio FHLT Stock Details FHLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1	Closed	-$11	–	10375
2024 Q1	$11	Sell	1 -36	-97%	-$390	﹤0.01%	9092
2023 Q4	$395	Sell	37 -107	-74%	-$1.13K	﹤0.01%	8685
2023 Q3	$1.52K	Buy	+144	New	+$1.5K	﹤0.01%	7912
2023 Q1	–	Sell	-702	Closed	-$7.09K	–	10796
2022 Q4	$7.09K	Buy	702 +202	+40%	+$2.04K	﹤0.01%	8941
2022 Q3	$5K	Buy	+500	New	+$4.98K	﹤0.01%	9258

Other funds holding FHLT

RCM

Robinson Capital Management Grosse Pointe Farms, Michigan $226M AUM 6.92% 1-Year Est. Return

UBS Group's FHLT Position: Q2 2024 in Review

UBS Group sold out of Future Health ESG Corp. Common stock (FHLT) in Q2 2024, closing a stake of 1 share — an estimated $11 sold.

UBS Group first reported a position in FHLT in Q3 2022 and held it in 5 quarters. The position peaked at $7.09K in Q4 2022. 1 fund tracked by Wall St. Rank holds FHLT as of Q2 2024.

UBS Group reported no remaining Future Health ESG Corp. Common stock position as of Q2 2024 after selling out during the quarter.
UBS Group sold 1 Future Health ESG Corp. Common stock share in Q2 2024, an estimated $11.
UBS Group first reported a position in Future Health ESG Corp. Common stock in Q3 2022 and held it in 5 quarters.
UBS Group's Future Health ESG Corp. Common stock position peaked at $7.09K in Q4 2022.
1 fund tracked by Wall St. Rank held Future Health ESG Corp. Common stock as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.